Resultados de la búsqueda 211-220 of 3002 for VEO-IBD

  1. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    The natural course of autosomal dominant polycystic kidney disease (ADPKD) is highly variable and typically characterized by progressive enlargement of cysts ...

  2. Radiología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to address a knowledge gap. Early diagnosis of nerve root avulsion injuries following brachial plexus trauma remain a barrier to ...

  3. Radiología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to address a knowledge gap. Early diagnosis of nerve root avulsion injuries following brachial plexus trauma remain a barrier to ...

  4. Mayo Clinic Ophthalmology Physician Update - August 2023

    Page 1.

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This resource-platform will be named Project BTTRFLY (Benevolent Tumor Tissue Repository Fighting for the Legacy of our Young). A Study of Leukemia Inhibitory ...

  6. Cirugía - Ensayos clínicos - Mayo Clinic

    Some patients undergoing trigger finger surgery with a pre-existing Dupuytren's cord may develop a thickened surgical scar after surgery, which can cause ...

  7. La salud de adolescentes y preadolescentes Noticias de la Mayo Clinic

    La salud de adolescentes y preadolescentes: desde el acondicionamiento físico y la nutrición hasta la educación sexual y el acoso.

  8. Salud del adulto LGBTQ health - Mayo Clinic

    IBD Pride Clinic: Belonging while battling bowel disease June 28, 2024, 05:00 p.m. CDT · Mayo Clinic Minute: Fireworks safety tips June 27, 2024, 03:00 p.m. ...

  9. Salud del adulto - Mayo Clinic

    IBD Pride Clinic: Belonging while battling bowel disease June 28, 2024, 05:00 p.m. CDT · Mayo Clinic Minute: Fireworks safety tips June 27, 2024, 03:00 p.m. ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Venetoclax may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Giving venetoclax with ibrutinib and rituximab with ...